A highly rifampicin resistant Mycobacterium tuberculosis strain emerging in Southern Brazil
Maria Lúcia Rosa RossettiiD, Pedro Eduardo Almeida da SilvaiD, Richard Steiner SalvatoiD, Ana Júlia ReisiD, Sun Hee SchiefelbeiniD, Andréa von GrolliD, Regina Bones BarcellosiD, Raquel de Abreu Maschmann, Leonardo Souza EstevesiD, Fernanda Sá Spies, Rúbia Raubach Trespach, Elis Regina Dalla CostaiD, Hermes Luís Neubauer de AmorimiD
Abstract
Here we described phenotypical, molecular and epidemiological features of a highly rifampicin-resistant Mycobacterium tuberculosis strain emerging in Southern Brazil, that carries an uncommon insertion of 12 nucleotides at the codon 435 in the rpoB gene. Employing a whole-genome sequencing-based study on drug-resistant Mycobacterium tuberculosis strains, we identified this emergent strain in 16 (9.19%) from 174 rifampicin-resistant clinical strains included. Nine of these 16 strains were available to minimum inhibitory concentration determination and for all of them was found a high rifampicin-resistance level ([≥] to 32 mg/L). This high resistance level could be explained by structural changes into the RIF binding site of RNA polymerase caused by the insertions, and consequent low-affinity interaction with rifampicin complex confirmed through protein modeling and molecular docking simulations. Epidemiological investigation showed that most of the individuals (56.25%) infected by the studied strains were prison inmate individuals or that spent some time in prison. The phylogenomic approach revealed that all strains carrying on the 12 nucleotide insertion belonged to the same genomic cluster, evidencing a communal transmission chain involving inmate individuals and community. We stress the importance of tuberculosis genomic surveillance and the introduction of measures to interrupt the Mycobacterium tuberculosis transmission chain in this region.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 9
- FWCI
- 0.20
- Field percentile
- top 32%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rifampicin and rifabutin resistance in 1000 Mycobacterium tuberculosis clinical isolates
M. R. Farhat, J. Sixsmith, … M. Murray·bioRxiv·Sep 25, 2018
- Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda
David Patrick Kateete, Shakira Namakula, … Moses Lutaakome Joloba·PLoS ONEPeer-reviewed·Dec 4, 2025
- HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis
C. Loiseau, D. Brites, … S. Gagneux·bioRxiv·Jul 20, 2020
- Novel and Reported Compensatory Mutations in rpoABC Associate Specifically with Predominant Mycobacterium tuberculosis Rifampicin Resistance Marker rpoB:S450L
D. Conkle-Gutierrez, S. M. Ramirez-Busby, … F. Valafar·bioRxiv·Feb 22, 2022
- Association between the rifampicin resistance mutations and rifabutin susceptibility in Mycobacterium tuberculosis: a meta-analysis
- Extensive endemic transmission of multidrug resistant Mycobacterium tuberculosis in Bhutan: A retrospective genomic-epidemiological study
Thinley Dorji, Karchung Tshering, … Patiyan Andersson·Open Forum Infectious DiseasesPeer-reviewed·Dec 26, 2025